'It' scares off competition in tight box office race

(MENAFN- AFP) It was knocked into second place last week -- but as Halloween approaches, freaky box office sensation "It" was back at number one in its fourth week in cinemas, industry estimates showed Sunday.

Starring Bill Skarsgard as a creepy clown who terrorizes a sleepy Maine town, "It" -- the highest-grossing horror movie of all time -- earned $17.3 million, according to Exhibitor Relations.

That is some $12.4 million less than last week's $29.7 million takings -- but still enough for the top spot, bringing total earnings to a colossal $291.1 million.

Close behind in the tight race for number one was Universal's newly-released "American Made," which raked in $17 million.

Starring Tom Cruise, "American Made" tells the story of a commercial airline pilot recruited to carry out reconnaissance missions over South America for the CIA.

Espionage comedy -- and last week's number one -- "Kingsman: The Golden Circle" came in at number three, also with takings of $17 million.

With a star-studded cast featuring Colin Firth, Channing Tatum, Halle Berry and even Elton John, "Kingsman" sees a British spy organization join forces with its American counterpart to take on a new global threat.

But despite its A-list lineup, it took less than half of last week's $39 million earnings.

Sitting comfortably in fourth place, having rung up $12 million, was animation "The Lego Ninjago Movie" -- the third installment of Warner Bros.' "The Lego Movie" franchise.

Sony's remake of horror film "Flatliners" did just that in its first week in theaters, earning an anti-climactic $6.7 million.

Originally released in 1990, "Flatliners" follows five medical students who try to find out if there is life after death by conducting experiments that cause near-death experiences.

Rounding out the top 10 were:

"Battle Of The Sexes" ($3.4 million)

"American Assassin" ($3.3 million)

"Home Again" ($1.7 million)

"Til Death Do Us Part" ($1.5 million)

"Mother!" ($1.4 million)


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.